Edgewise Therapeutics
Ericka Benson is a highly experienced professional in the pharmaceutical industry, with a strong background in program and project management. With an extensive career history in companies like Pfizer, Covidien, Astria Therapeutics, Inc., and currently at Edgewise Therapeutics, Ericka has showcased their expertise in leading the advancement of programs from preclinical stages to early commercial planning. With a solid educational background in microbiology, molecular genetics, and medical sciences, Ericka has demonstrated their proficiency in delivering successful preclinical programs in various disease areas.
This person is not in any teams
This person is not in any offices
Edgewise Therapeutics
1 followers
Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise recently closed it’s Series B financing round which will support the advancement of Edgewise Therapeutic’s lead product candidate into clinical development for Duchenne and Becker Muscular Dystrophy (DMD and BMD) as well as expansion of the company’s pipeline. The company’s leadership team has founded multiple biotechnology startups, several of which have gone on to become publicly-traded companies and brings to bear a depth of experience in drug discovery, development and commercialization.